PharmaTher Provides Corporate Update Following FDA Approval of Ketamine (KETARx™)
Company advancing U.S. commercialization with FDA-approved ketamine and rare disorder NDA filingsTORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings...
Company advancing U.S. commercialization with FDA-approved ketamine and rare disorder NDA filingsTORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings...
SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell...
TEL AVIV, Israel, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a...
WALTHAM, Mass. and BOULDER, Colo., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
Targeting the Multi-Trillion Dollar Longevity Market Jupiter, Florida, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter”...
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - August 26, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
Winter Park, Florida--(Newsfile Corp. - August 26, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a bold leader in regenerative medicine...
New study shows longitudinal biomarker trajectories support personalized patient managementManassas, Virginia--(Newsfile Corp. - August 26, 2025) - A new study...
Announced unprecedented Phase 1b/2a topline results in chronic spinal cord injury NVG-291 is the first pharmacologic candidate to demonstrate statistically...
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTD) (FSE: E8D0) (the "Company"...
STOCKHOLM, Aug. 26, 2025 /PRNewswire/ -- Encare AB today announced that its ERAS® Interactive Audit System (EIAS) has been qualified...
PALO ALTO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Bioz, Inc., a leader in AI-powered scientific literature analysis...